Korea, U.S. agrees to shorten reimburse notice by 20 days

The governments of Korea and the U.S. agreed that the reimbursement notice of pharmaceutical products and medical devices should be shorted by 20 days from this January, according to the Korea Drug Research Association (KDRA).

The KDRA said that the nation’s innovative drug firms repeatedly asked for the Ministry of Health and Welfare to shorten the reimbursement notice in March and July of ...